ReviewArchives of microbiology2026
Microbial secretome-mediated nanotechnology: an antibacterial strategy for future.
Review in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biological synthesis of nanoparticles has been widely explored as a sustainable alternative to physical and chemical routes. Nevertheless, the majority of current methods are based on intact microbial cells or crude plant extracts, which leads to lack of reproducibility, biomolecular interference, and difficulties in mechanistic interpretation and scale-up. We present microbial secretome-mediated nanotechnology as a new and under researched paradigm in this review, which separates nanoparticle synthesis from cellular complexity and preserves biological precision. We quantitatively analyze the composition of microbial secretomes, redox enzymes, extracellular proteins, peptides, polysaccharides, and membrane-derived vesicles and map their respective functions in nanoparticle nucleation, growth, stabilization, and functionalization. Emerging biochemical and mechanistic evidence is creating a direct understanding of how the composition of the secretome relates to the nanoparticle morphology, surface chemistry, and bioactivity, moving beyond organism-specific reports. Notably, we critically assess secretome-mediated synthesis by comparing and contrasting it with whole-cell and plant-extract techniques, highlighting specific benefits including; enhanced batch-to-batch reproducibility, minimized polysaccharide and biomass contamination, better control over particle size and shape, reduced toxicity hazards, and increased feasibility of downstream processing and scale-up. Emerging approaches, such as secretome fractionation, omics-inspired secretome engineering, and vesicle-mediated nano-delivery, are mentioned as directions for developing tunable and application-specific nanomaterials. Altogether, the given review offers a mechanistic and translational roadmap of the microbial secretome-mediated nanotechnology, which cannot be regarded as the extension of green synthesis, but rather as a controllable bio-nanoengineering platform with significant potential in medical, agrarian, and environmental cleanup fields.
Indexed as
Identifiers
41724855What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.